We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

12 hedge funds and large institutions have $15.9M invested in Entera Bio in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

353% more call options, than puts

Call options by funds: $752K | Put options by funds: $166K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.05% less ownership

Funds ownership: 19.7% → 19.65% (-0.05%)

14% less funds holding

Funds holding: 14 → 12 (-2)

40% less capital invested

Capital invested by funds: $26.7M → $15.9M (-$10.8M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
2
Reduced
4
Closed
4
Calls
$752K
Puts
$166K
Net Calls
+$586K
Net Calls Change
-$23K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$150K
2
AWM
Altium Wealth Management
New York
+$44.3K
3
AIM
ARK Investment Management
Florida
+$29.7K
4
Morgan Stanley
Morgan Stanley
New York
+$2.21K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$89K
2
Simplex Trading
Simplex Trading
Illinois
-$69.4K
3
Jane Street
Jane Street
New York
-$54K
4
Citadel Advisors
Citadel Advisors
Florida
-$46K
5
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$15.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$6.99M – – –
RCM
2
RA Capital Management
Massachusetts
$6.62M – – –
AIM
3
ARK Investment Management
Florida
$1.95M +$29.7K +7,915 +1%
Renaissance Technologies
4
Renaissance Technologies
New York
$113K +$150K +40,100 New
Citadel Advisors
5
Citadel Advisors
Florida
$78K -$46K -12,270 -31%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$49K – – –
Bank of America
7
Bank of America
North Carolina
$39K -$8.64K -2,307 -14%
AWM
8
Altium Wealth Management
New York
$33K +$44.3K +11,830 New
SFI
9
Susquehanna Fundamental Investments
Pennsylvania
$29K -$15.7K -4,200 -29%
Morgan Stanley
10
Morgan Stanley
New York
$17K +$2.21K +590 +11%
Simplex Trading
11
Simplex Trading
Illinois
$2K -$69.4K -18,529 -95%
Millennium Management
12
Millennium Management
New York
– -$89K -18,839 Closed
Jane Street
13
Jane Street
New York
– -$54K -11,563 Closed
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
– -$9K -1,894 Closed
UBS Group
15
UBS Group
Switzerland
– -$3K -565 Closed

ENTX Hedge Fund Activity: Q4 2021 in Review

12 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q4 2021, worth a combined $15.9M — down 40% from $26.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ENTX and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $150K. The largest seller was Millennium Management, exiting entirely with an estimated $89K sold.

  • 12 institutional investors held Entera Bio (ENTX) as of Q4 2021, down from 14 in Q3 2021.
  • Funds reported $15.9M of Entera Bio stock for Q4 2021, down 40% quarter-over-quarter.
  • 2 funds opened new Entera Bio positions in Q4 2021 and 4 closed out, a net change of -2 holders.
  • The largest Entera Bio buyer in Q4 2021 was Renaissance Technologies, an estimated $150K added.
  • The largest Entera Bio seller in Q4 2021 was Millennium Management, an estimated $89K sold.

Based on aggregated 13F filings for Q4 2021.